ACLX
Arcellx Inc
NASDAQ: ACLX · HEALTHCARE · BIOTECHNOLOGY
$115.07
+0.00% today
Updated 2026-04-28
Market cap
$6.73B
P/E ratio
—
P/S ratio
302.04x
EPS (TTM)
$-4.07
Dividend yield
—
52W range
$48 – $115
Volume
2.8M
Arcellx Inc (ACLX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $15.81M | $43.59M | $57.69M | $128.78M | $313.82M | $825.13M | $711.33M |
| Cash & equivalents | — | — | — | — | — | — | — |
| Current assets | $14.63M | $38.07M | $49.36M | $112.81M | $266.86M | $716.36M | $599.31M |
| Total liabilities | $1.82M | $76.33M | $7.15M | $250.30M | $108.86M | $339.75M | $256.54M |
| Current liabilities | $1.82M | $3.04M | $5.27M | $14.85M | $56.69M | $118.24M | $125.41M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — |
| Retained earnings | $-15.07M | $-33.05M | $-65.14M | $-130.11M | $-318.79M | $-389.48M | $-496.83M |
| Accounts receivable | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — |